Medpace Holdings Stock News

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.

Medpace Holdings, Inc. (NASDAQ:MEDP ) Q1 2022 Earnings Conference Call April 26, 2022 9:00 AM ET Company Participants Lauren Morris – Director-Investor Relations August Troendle – Chief Executive

Medpace Holdings Inc's (NASDAQ: MEDP) Q1 revenue increased 27.3% Y/Y to $330.9 million, beating the consensus of $327.09 million. On a constant currency organic basis, revenue increased 28.1%.

Medpace (MEDP) delivered earnings and revenue surprises of 34.13% and 1.11%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Medpace Holdings is a healthy business trading at a discount to its intrinsic value. Price target $193-200.

Medpace Holdings Inc. (NASDAQ:MEDP) shares, rose in value on Friday, 03/11/22, with the stock price down by -4.73% to the previous day’s close as strong demand from buyers drove the stock to $141.20. Actively observing the price movement in the last trading, the stock closed the session at $148.21, falling within a range of $140.77 … Medpace Holdings Inc. (NASDAQ: MEDP): Moving Toward A Higher Share Price Read More »

Wasatch Global Investors, an investment management firm, published its “Wasatch Small Cap Growth Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

What do they know, how? By a community of over 100,000 world-wide information-gatherers reporting back to Market-Maker HQ trading desks.

In the last trading session, 2.26 million shares of the Medpace Holdings Inc. (NASDAQ:MEDP) were traded, and its beta was 1.44. Most recently the company’s share price was $138.87, and it changed around -$35.36 or -20.30% from the last close, which brings the market valuation of the company to $5.03B. MEDP currently trades at a … Medpace Holdings Inc. (NASDAQ: MEDP) Could See Prices Soar In The Coming Months Read More »

The heavy selling pressure might have exhausted for Medpace (MEDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in

MEDP earnings call for the period ending December 31, 2021.

Although Medpace Holdings (MEDP) Q4 2021 results beat on the bottom line, its stock price took a licking today as some investors may have been disappointed by its FY 2022 outlook.